QRVO
25
17
IBM
48
4
CMG
51
-3
APH
48
3
BEN
36
4
TDC
55
-2
FAST
30
2
EW
46
10
AIV
47
-3
TXN
35
7
TRV
42
3
AAL
41
-4
VTR
35
3
JNPR
67
2
PAYX
38
2
TMO
56
4
STI
46
-4
CMI
52
3
ADBE
44
-2
PLD
35
5
QRVO
25
17
IBM
48
4
CMG
51
-3
APH
48
3
BEN
36
4
TDC
55
-2
FAST
30
2
EW
46
10
AIV
47
-3
TXN
35
7
TRV
42
3
AAL
41
-4
VTR
35
3
JNPR
67
2
PAYX
38
2
TMO
56
4
STI
46
-4
CMI
52
3
ADBE
44
-2
PLD
35
5
Financhill
Back

Amphastar Pharmaceuticals 10K Form

Sell
27

AMPH
Amphastar Pharmaceuticals

Last Price:
$36.28
Seasonality Move:
2.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMPH News And Ratings

See the #1 stock for the next 7 days that we like better than AMPH

AMPH Financial Statistics

Sales & Book Value

Annual Sales: $644.4M
Cash Flow: $46.2M
Price / Cash Flow: 11.2
Annual Sales: $15.04
Price / Book: 2.4

Profitability

EPS (TTM): 3.00000
Net Income (TTM): $157.7M
Gross Margin: $351.1M
Return on Equity: 23.56%
Return on Assets: 10.28%

Amphastar Pharmaceuticals Earnings Forecast

Key Amphastar Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 21 years for AMPH is 54.49%.
  • The Selling, General & Administrative Expenses for AMPH have been equal to 12.48% of Gross Profit Margin.
  • The Research & Development expenses have been 11.44% of Revenue.
  • The Interest Expense is 19.74% of Operating Income.
  • The Net Earning history of AMPH is 21.34% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 10 years.

Amphastar Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMPH
CUSIP: 03209R
Website: amphastar.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 3.43
Quick Ratio: 2.49

Price-to-Earnings

Trailing P/E Ratio: 13.96
Forward P/E Ratio: 7.56

AMPH Technical Analysis vs Fundamental Analysis

Sell
27
Amphastar Pharmaceuticals (AMPH) is a Sell

Is Amphastar Pharmaceuticals a Buy or a Sell?